✦ LIBER ✦

Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancer

✍ Scribed by Hazzan, Azzour D; Shah, Hitesh H; Hong, Susana; Sakhiya, Vipulbhai; Wanchoo, Rimda; Fishbane, Steven

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Editorial: Intersecting Guidelines: Admi

✍ Charles L. Bennett; Pamela S. Becker; Eric H. Kraut; Athena T. Samaras; Dennis P 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

161 Patient Characteristics Associated w

✍ Marie-Hélène Lafeuille; Robert A. Bailey; Mekré Senbetta; Patrick Lefebvre 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 234 KB

Erythropoiesis-stimulating agents for an

✍ Sheikh, Semira; Littlewood, Tim J 📂 Article 📅 2010 🏛 Expert Reviews 🌐 English ⚖ 224 KB

Association of anemia and erythropoiesis

✍ Keithi-Reddy, Sai Ram; Addabbo, Francesco; Patel, Tejas V; Mittal, Bharati V; Go 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 175 KB

Safety issues related to erythropoiesis-

✍ Del Vecchio, Lucia; Locatelli, Francesco 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 240 KB

153: Dosing Intervals and Hemoglobin Con

✍ Saul Nurko; Rita Spirko; Amy Law; Vincent W. Dennis 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 191 KB